참고문헌 (90)

1. Acuña S. M. Floeter-Winter L. M. Muxel S. M. ( 2020 ). MicroRNAs: Biological Regulators in Pathogen-Host Interactions . Cells 9 ( 1 ), 113 . 10.3390/cells9010113 

   상세보기

2. Adhikari B. Marasini B. P. Rayamajhee B. Bhattarai B. R. Lamichhane G. Khadayat K. ( 2020 ). Potential Roles of Medicinal Plants for the Treatment of Viral Diseases Focusing on COVID-19: A Review . Phytother. Res. 35 , 1298 . 10.1002/ptr.6893 33037698 

   상세보기

3. Aleem A. Akbar Samad A. B. Slenker A. K. ( 2021 ). Emerging Variants of SARS-CoV-2 and Novel Therapeutics against Coronavirus (COVID-19) . Treasure Island (FL) : StatPearls . 

4. Bertilsson G. Heidrich J. Svensson K. Asman M. Jendeberg L. Sydow-Bäckman M. ( 1998 ). Identification of a Human Nuclear Receptor Defines a New Signaling Pathway for CYP3A Induction . Proc. Natl. Acad. Sci. U S A. 95 ( 21 ), 12208 – 12213 . 10.1073/pnas.95.21.12208 9770465 

   상세보기

5. Blanco-Melo D. Nilsson-Payant B. E. Liu W. C. Uhl S. Hoagland D. Møller R. ( 2020 ). Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 . Cell 181 ( 5 ), 1036 . 10.1016/j.cell.2020.04.026 32416070 

   상세보기

6. Breikaa R. M. Lilly B. ( 2021 ). The Notch Pathway: A Link between COVID-19 Pathophysiology and its Cardiovascular Complications . Front. Cardiovasc. Med. 8 , 681948 . 10.3389/fcvm.2021.681948 34124207 

   상세보기

7. Buchrieser J. Dufloo J. Hubert M. Monel B. Planas D. Rajah M. M. ( 2020 ). Syncytia Formation by SARS-CoV-2-Infected Cells . EMBO J. 39 ( 23 ), e106267 . 10.15252/embj.2020106267 33051876 

   상세보기

8. Catalano A. Iacopetta D. Pellegrino M. Aquaro S. Franchini C. Sinicropi M. S. ( 2021 ). Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics . Antibiotics (Basel) 10 ( 1 ), 92 . 10.3390/antibiotics10010092 33477901 

   상세보기

9. Chandan K. Gupta M. Sarwat M. ( 2019 ). Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation during Infectious and Inflammatory Diseases . Front. Immunol. 10 , 3081 . 10.3389/fimmu.2019.03081 32038627 

   상세보기

10. Chandra A. Chaudhary M. Qamar I. Singh N. Nain V. ( 2021 ). In Silico identification and Validation of Natural Antiviral Compounds as Potential Inhibitors of SARS-CoV-2 Methyltransferase . J. Biomol. Struct. Dyn. 15 , 1 – 11 . 10.1080/07391102.2021.1886174 

    상세보기

11. Chen Y. Wang X. ( 2020 ). miRDB: an Online Database for Prediction of Functional microRNA Targets . Nucleic Acids Res. 48 ( D1 ), D127 – D31 . 10.1093/nar/gkz757 31504780 

    상세보기

12. Cheng Y. W. Chao T. L. Li C. L. Chiu M. F. Kao H. C. Wang S. H. ( 2020 ). Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects . Cell Rep. 33 ( 2 ), 108254 . 10.1016/j.celrep.2020.108254 33007239 

    상세보기

13. Choudhary S. Sharma K. Singh H. Silakari O. ( 2021 ). The Interplay between Inflammatory Pathways and COVID-19: A Critical Review on Pathogenesis and Therapeutic Options . Microb. Pathog. 150 , 104673 . 10.1016/j.micpath.2020.104673 33278517 

    상세보기

14. Chu Q. Gao Y. Bi D. Xu T. ( 2017 ). MicroRNA-148 as a Negative Regulator of the Common TLR Adaptor Mediates Inflammatory Response in Teleost Fish . Sci. Rep. 7 ( 1 ), 4124 . 10.1038/s41598-017-04354-9 28646187 

    상세보기

15. da Silva R. P. Gonçalves J. I. B. Zanin R. F. Schuch F. B. de Souza A. P. D. ( 2021 ). Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis . Front. Immunol. 12 , 657363 . 10.3389/fimmu.2021.657363 34054820 

    상세보기

16. Davies N. G. Jarvis C. I. Group C. C-W. Edmunds W. J. Jewell N. P. Diaz-Ordaz K. ( 2021 ). Increased Mortality in Community-Tested Cases of SARS-CoV-2 Lineage B.1.1.7 . Nature 593 ( 7858 ), 270 – 274 . 10.1038/s41586-021-03426-1 33723411 

    상세보기

17. Davies N. G. Abbott S. Barnard R. C. Jarvis C. I. Kucharski A. J. Munday J. D. ( 2021 ). Estimated Transmissibility and Impact of SARS-CoV-2 Lineage B.1.1.7 in England . Science 372 ( 6538 ), eabg3055 . 10.1126/science.abg3055 33658326 

    상세보기

18. Ding Y. Zeng L. Li R. Chen Q. Zhou B. Chen Q. ( 2017 ). The Chinese Prescription Lianhuaqingwen Capsule Exerts Anti-influenza Activity through the Inhibition of Viral Propagation and Impacts Immune Function . BMC Complement. Altern. Med. 17 ( 1 ), 130 . 10.1186/s12906-017-1585-7 28235408 

    상세보기

19. Ding Y. Cao Z. Cao L. Ding G. Wang Z. Xiao W. ( 2017 ). Antiviral Activity of Chlorogenic Acid against Influenza A (H1N1/H3N2) Virus and its Inhibition of Neuraminidase . Sci. Rep. 7 , 45723 . 10.1038/srep45723 28393840 

    상세보기

20. DynaMed ( 1995 ). EBSCO Information Services . [Internet] . Available at: http://www.www.dynamed.com (Accessed April 20, 2021) . 

21. El Gizawy H. A. Boshra S. A. Mostafa A. Mahmoud S. H. Ismail M. I. Alsfouk A. A. ( 2021 ). Pimenta Dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-inflammatory Activities: Molecular Docking and Dynamics, In Vitro , and In Vivo Studies . Molecules 26 ( 19 ), 5844 . 10.3390/molecules26195844 34641388 

    상세보기

22. Fu J. Wang Z. Huang L. Zheng S. Wang D. Chen S. ( 2014 ). Review of the Botanical Characteristics, Phytochemistry, and Pharmacology of Astragalus Membranaceus (Huangqi) . Phytother Res. 28 ( 9 ), 1275 – 1283 . 10.1002/ptr.5188 25087616 

    상세보기

23. Ge L. Xiao L. Wan H. Li J. Lv K. Peng S. ( 2019 ). Chemical Constituents from Lonicera japonica Flower Buds and Their Anti-hepatoma and Anti-HBV Activities . Bioorg. Chem. 92 , 103198 . 10.1016/j.bioorg.2019.103198 31446242 

    상세보기

24. Guo Y. R. Cao Q. D. Hong Z. S. Tan Y. Y. Chen S. D. Jin H. J. ( 2020 ). The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak - an Update on the Status . Mil. Med. Res. 7 ( 1 ), 11 . 10.1186/s40779-020-00240-0 32169119 

    상세보기

25. Han H. Ma Q. Li C. Liu R. Zhao L. Wang W. ( 2020 ). Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 Are Disease Severity Predictors . Emerg. Microbes Infect. 9 ( 1 ), 1123 – 1130 . 10.1080/22221751.2020.1770129 32475230 

    상세보기

26. Hoffmann M. Kleine-Weber H. Schroeder S. Kruger N. Herrler T. Erichsen S. ( 2020 ). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor . Cell 181 , 271 . 10.1016/j.cell.2020.02.052 32142651 

    상세보기

27. Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. ( 2020 ). Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China . Lancet 395 ( 10223 ), 497 – 506 . 10.1016/S0140-6736(20)30183-5 31986264 

    상세보기

28. Jia S. Luo H. Liu X. Fan X. Huang Z. Lu S. ( 2021 ). Dissecting the Novel Mechanism of Reduning Injection in Treating Coronavirus Disease 2019 (COVID-19) Based on Network Pharmacology and Experimental Verification . J. Ethnopharmacol. 273 , 113871 . 10.1016/j.jep.2021.113871 33485971 

    상세보기

29. Jiang S. Yan W. Wang S. E. Baltimore D. ( 2019 ). Dual Mechanisms of Posttranscriptional Regulation of Tet2 by Let-7 microRNA in Macrophages . Proc. Natl. Acad. Sci. U S A. 116 ( 25 ), 12416 – 12421 . 10.1073/pnas.1811040116 31160465 

    상세보기

30. Jin S. Zeng X. Fang J. Lin J. Chan S. Y. Erzurum S. C. ( 2019 ). A Network-Based Approach to Uncover microRNA-Mediated Disease Comorbidities and Potential Pathobiological Implications . NPJ Syst. Biol. Appl. 5 , 41 . 10.1038/s41540-019-0115-2 31754458 

    상세보기

31. Kliewer S. A. Goodwin B. Willson T. M. ( 2002 ). The Nuclear Pregnane X Receptor: a Key Regulator of Xenobiotic Metabolism . Endocr. Rev. 23 ( 5 ), 687 – 702 . 10.1210/er.2001-0038 12372848 

    상세보기

32. Kupferschmidt K. Cohen J. ( 2020 ). Race to Find COVID-19 Treatments Accelerates . Science 367 ( 6485 ), 1412 – 1413 . 10.1126/science.367.6485.1412 32217705 

    상세보기

33. Lau J. T. Leung P. C. Wong E. L. Fong C. Cheng K. F. Zhang S. C. ( 2005 ). The Use of an Herbal Formula by Hospital Care Workers during the Severe Acute Respiratory Syndrome Epidemic in Hong Kong to Prevent Severe Acute Respiratory Syndrome Transmission, Relieve Influenza-Related Symptoms, and Improve Quality of Life: a Prospective Cohort Study . J. Altern. Complement. Med. 11 ( 1 ), 49 – 55 . 10.1089/acm.2005.11.49 15750363 

    상세보기

34. Lee Y. R. Yeh S. F. Ruan X. M. Zhang H. Hsu S. D. Huang H. D. ( 2017 ). Honeysuckle Aqueous Extract and Induced Let-7a Suppress Dengue Virus Type 2 Replication and Pathogenesis . J. Ethnopharmacol. 198 , 109 – 121 . 10.1016/j.jep.2016.12.049 28052239 

    상세보기

35. Lee Y. R. Chang C. M. Yeh Y. C. Huang C. F. Lin F. M. Huang J. T. ( 2021 ). Honeysuckle Aqueous Extracts Induced Let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2 . Viruses 13 ( 2 ), 308 . 10.3390/v13020308 33669264 

    상세보기

36. Leng Z. Zhu R. Hou W. Feng Y. Yang Y. Han Q. ( 2020 ). Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia . Aging Dis. 11 ( 2 ), 216 – 228 . 10.14336/AD.2020.0228 32257537 

    상세보기

37. Li H. B. Yu Y. Mei Y. D. Meng Z. Q. Wang Z. Z. Huang W. Z. ( 2017 ). A New Hetero Dimeric Terpenoid Derivative, Japonicaside C, from the Flower Buds of Lonicera japonica . Nat. Prod. Res. 31 ( 2 ), 143 – 148 . 10.1080/14786419.2016.1219859 27573377 

    상세보기

38. Li J J. Ye C. Chang C. ( 2020 ). Comparative Transcriptomics Analysis Revealing Flower Trichome Development during Flower Development in Two Lonicera japonica Thunb. Cultivars Using RNA-Seq . BMC Plant Biol. 20 ( 1 ), 341 . 10.1186/s12870-020-02546-6 32680457 

    상세보기

39. Li RJ R. J. Kuang X. P. Wang W. J. Wan C. P. Li W. X. ( 2020 ). Comparison of Chemical Constitution and Bioactivity Among Different Parts of Lonicera japonica Thunb . J. Sci. Food Agric. 100 ( 2 ), 614 – 622 . 10.1002/jsfa.10056 31597198 

    상세보기

40. Li X X. Geng M. Peng Y. Meng L. Lu S. ( 2020 ). Molecular Immune Pathogenesis and Diagnosis of COVID-19 . J. Pharm. Anal. 10 ( 2 ), 102 – 108 . 10.1016/j.jpha.2020.03.001 32282863 

    상세보기

41. Liu B. Zhao H. Wang Y. Zhang H. Ma Y. ( 2020 ). Astragaloside IV Attenuates Lipopolysaccharides-Induced Pulmonary Epithelial Cell Injury through Inhibiting Autophagy . Pharmacology 105 ( 1-2 ), 90 – 101 . 10.1159/000502865 31554002 

    상세보기

42. Liu M. Gao Y. Yuan Y. Yang K. Shi S. Tian J. ( 2021 ). Efficacy and Safety of Herbal Medicine (Lianhuaqingwen) for Treating COVID-19: A Systematic Review and Meta-Analysis . Integr. Med. Res. 10 ( 1 ), 100644 . 10.1016/j.imr.2020.100644 32864332 

    상세보기

43. Lucas M. Karrer U. Lucas A. Klenerman P. ( 2001 ). Viral Escape Mechanisms-Eescapology Taught by Viruses . Int. J. Exp. Pathol. 82 ( 5 ), 269 – 286 . 10.1046/j.1365-2613.2001.00204.x 11703537 

    상세보기

44. Luo H. Tang Q. L. Shang Y. X. Liang S. B. Yang M. Robinson N. ( 2020 ). Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs . Chin. J. Integr. Med. 26 ( 4 ), 243 – 250 . 10.1007/s11655-020-3192-6 32065348 

    상세보기

45. Ma Q. Liang D. Song S. Yu Q. Shi C. Xing X. ( 2017 ). Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and its Bioactive Compound Mixture against Human Adenovirus III In Vitro . Viruses 9 ( 4 ), 79 . 10.3390/v9040079 

    상세보기

46. Mandel M. Harari G. Gurevich M. Achiron A. ( 2020 ). Cytokine Prediction of Mortality in COVID19 Patients . Cytokine 134 , 155190 . 10.1016/j.cyto.2020.155190 32673995 

    상세보기

47. Meganck R. M. Baric R. S. ( 2021 ). Developing Therapeutic Approaches for Twenty-First-century Emerging Infectious Viral Diseases . Nat. Med. 27 ( 3 ), 401 – 410 . 10.1038/s41591-021-01282-0 33723456 

    상세보기

48. Meletis C. D. Wilkes K. ( 2020 ). Immune Competence and Minimizing Susceptibility to COVID-19 and Other Immune System Threats . Altern. Ther. Health Med. 26 ( S2 ), 94 – 99 . 33245701 

49. Ng A. W. T. Poon S. L. Huang M. N. Lim J. Q. Boot A. Yu W. ( 2017 ). Aristolochic Acids and Their Derivatives Are Widely Implicated in Liver Cancers in Taiwan and throughout Asia . Sci. Transl. Med. 9 ( 412 ), eaan6446 . 10.1126/scitranslmed.aan6446 29046434 

    상세보기

50. Oran D. P. Topol E. J. ( 2020 ). Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review . Ann. Intern. Med. 173 ( 5 ), 362 – 367 . 10.7326/M20-3012 32491919 

    상세보기

51. Poon P. M. Wong C. K. Fung K. P. Fong C. Y. Wong E. L. Lau J. T. ( 2006 ). Immunomodulatory Effects of a Traditional Chinese Medicine with Potential Antiviral Activity: a Self-Control Study . Am. J. Chin. Med. 34 ( 1 ), 13 – 21 . 10.1142/S0192415X0600359X 16437735 

    상세보기

52. Raudvere U. Kolberg L. Kuzmin I. Arak T. Adler P. Peterson H. ( 2019 ). g:Profiler: a Web Server for Functional Enrichment Analysis and Conversions of Gene Lists (2019 Update) . Nucleic Acids Res. 47 ( W1 ), W191 – W8 . 10.1093/nar/gkz369 31066453 

    상세보기

53. Sabbatinelli J. Giuliani A. Matacchione G. Latini S. Laprovitera N. Pomponio G. ( 2021 ). Decreased Serum Levels of the Inflammaging Marker miR-146a Are Associated with Clinical Response to Tocilizumab in COVID-19 Patients . Mech. Ageing Dev. 193 , 111413 . 10.1016/j.mad.2020.111413 33307107 

    상세보기

54. Samavati L. Uhal B. D. ( 2020 ). ACE2, Much More Than Just a Receptor for SARS-COV-2 . Front. Cel. Infect. Microbiol. 10 , 317 . 10.3389/fcimb.2020.00317 

    상세보기

55. Shang X. Pan H. Li M. Miao X. Ding H. ( 2011 ). Lonicera japonica Thunb.: Ethnopharmacology, Phytochemistry and Pharmacology of an Important Traditional Chinese Medicine . J. Ethnopharmacol. 138 ( 1 ), 1 – 21 . 10.1016/j.jep.2011.08.016 21864666 

    상세보기

56. Shawan M. M. A. K. Halder S. K. Hasan M. A. ( 2021 ). Luteolin and Abyssinone II as Potential Inhibitors of SARS-CoV-2: an In Silico Molecular Modeling Approach in Battling the COVID-19 Outbreak . Bull. Natl. Res. Cent. 45 ( 1 ), 27 . 10.1186/s42269-020-00479-6 33495684 

    상세보기

57. Sheedy F. J. O'Neill L. A. ( 2008 ). Adding Fuel to Fire: microRNAs as a New Class of Mediators of Inflammation . Ann. Rheum. Dis. 67 ( Suppl. 3 ), iii50 . 10.1136/ard.2008.100289 19022814 

    상세보기

58. Shi L. Yin F. Xin X. Mao S. Hu P. Zhao C. ( 2014 ). Astragalus Polysaccharide Protects Astrocytes from Being Infected by HSV-1 through TLR3/NF-κB Signaling Pathway . Evid. Based Complement. Alternat. Med. 2014 , 285356 . 10.1155/2014/285356 25057274 

    상세보기

59. Shi T. H. Huang Y. L. Chen C. C. Pi W. C. Hsu Y. L. Lo L. C. ( 2020 ). Andrographolide and its Fluorescent Derivative Inhibit the Main Proteases of 2019-nCoV and SARS-CoV through Covalent Linkage . Biochem. Biophys. Res. Commun. 533 ( 3 ), 467 – 473 . 10.1016/j.bbrc.2020.08.086 32977949 

    상세보기

60. Shukla S. D. Fairbairn R. L. Gell D. A. Latham R. D. Sohal S. S. Walters E. H. ( 2016 ). An Antagonist of the Platelet-Activating Factor Receptor Inhibits Adherence of Both Nontypeable Haemophilus Influenzae and Streptococcus Pneumoniae to Cultured Human Bronchial Epithelial Cells Exposed to Cigarette Smoke . Int. J. Chron. Obstruct. Pulmon. Dis. 11 , 1647 – 1655 . 10.2147/COPD.S108698 27524890 

    상세보기

61. Singh R. Bhardwaj V. K. Sharma J. Kumar D. Purohit R. ( 2021 ). Identification of Potential Plant Bioactive as SARS-CoV-2 Spike Protein and Human ACE2 Fusion Inhibitors . Comput. Biol. Med. 136 , 104631 . 10.1016/j.compbiomed.2021.104631 34273770 

    상세보기

62. Stokkermans T. J. Trichonas G. ( 2020 ). Chloroquine and Hydroxychloroquine Toxicity . Treasure Island (FL) : StatPearls . 

63. Su C. M. Wang L. Yoo D. ( 2021 ). Activation of NF-κB and Induction of Proinflammatory Cytokine Expressions Mediated by ORF7a Protein of SARS-CoV-2 . Sci. Rep. 11 ( 1 ), 13464 . 10.1038/s41598-021-92941-2 34188167 

    상세보기

64. Subramanian A. Narayan R. Corsello S. M. Peck D. D. Natoli T. E. Lu X. ( 2017 ). A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles . Cell 171 ( 6 ), 1437 . 10.1016/j.cell.2017.10.049 29195078 

    상세보기

65. Sumon T. A. Hussain M. A. Hasan M. T. Hasan M. Jang W. J. Bhuiya E. H. ( 2020 ). A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic . Front. Mol. Biosci. 7 , 585899 . 10.3389/fmolb.2020.585899 33569389 

    상세보기

66. Suzuki Y. J. Nikolaienko S. I. Dibrova V. A. Dibrova Y. V. Vasylyk V. M. Novikov M. Y. ( 2021 ). SARS-CoV-2 Spike Protein-Mediated Cell Signaling in Lung Vascular Cells . Vascul. Pharmacol. 137 , 106823 . 10.1016/j.vph.2020.106823 33232769 

    상세보기

67. Tang H. Gao Y. Li Z. Miao Y. Huang Z. Liu X. ( 2020 ). The Noncoding and Coding Transcriptional Landscape of the Peripheral Immune Response in Patients with COVID-19 . Clin. Transl Med. 10 ( 6 ), e200 . 10.1002/ctm2.200 33135345 

    상세보기

68. UpToDate ( 1992 ). Wolters Kluwer . [Internet] . Available at: https://www.uptodate.com/ (Accessed April 20, 2021) . 

69. V'Kovski P. Kratzel A. Steiner S. Stalder H. Thiel V. ( 2021 ). Coronavirus Biology and Replication: Implications for SARS-CoV-2 . Nat. Rev. Microbiol. 19 ( 3 ), 155 – 170 . 10.1038/s41579-020-00468-6 33116300 

    상세보기

70. Wang M. Yu Y. Brad K. Xie W. Zhang X. Y. ( 2016 ). The Screening and Evaluation of Herbs and Identification of Herbal Combinations with Anti-viral Effects on Newcastle Disease Virus . Br. Poult. Sci. 57 ( 1 ), 34 – 43 . 10.1080/00071668.2015.1119245 26927474 

    상세보기

71. Wang C. Horby P. W. Hayden F. G. Gao G. F. ( 2020 ). A Novel Coronavirus Outbreak of Global Health Concern . Lancet 395 ( 10223 ), 470 – 473 . 10.1016/S0140-6736(20)30185-9 31986257 

    상세보기

72. Wang W.-X. Zhang Y.-R. Luo S.-Y. Zhang Y.-S. Zhang Y. Tang C. ( 2021 ). Chlorogenic Acid, a Natural Product as Potential Inhibitor of COVID-19: Virtual Screening experiment Based on Network Pharmacology and Molecular Docking . Nat. Product. Res. , 1 – 6 . 10.1080/14786419.2021.1904923 

    상세보기

73. Weng Y. H. Kuo K. N. Chen C. Yang C. Y. Lo H. L. Chiu Y. W. ( 2014 ). Profile of Evidence-Based Practice Among Respiratory Therapists in Taiwan . Respir. Care 59 ( 2 ), 281 – 287 . 10.4187/respcare.02611 23920218 

    상세보기

74. WHO ( 2007 ). WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region . Manila : World Health Organization Western Pacific Region . 

75. Wu Y. Zhang F. Yang K. Fang S. Bu D. Li H. ( 2019 ). SymMap: an Integrative Database of Traditional Chinese Medicine Enhanced by Symptom Mapping . Nucleic Acids Res. 47 ( D1 ), D1110 – D7 . 10.1093/nar/gky1021 30380087 

    상세보기

76. Wu C C. Chen X. Cai Y. Xia J. Zhou X. Xu S. ( 2020 ). Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China . JAMA Intern. Med. 180 ( 7 ), 934 – 943 . 10.1001/jamainternmed.2020.0994 32167524 

    상세보기

77. Wu Y Y. Wang Y. Gong S. Tang J. Zhang J. Li F. ( 2020 ). Ruscogenin Alleviates LPS-Induced Pulmonary Endothelial Cell Apoptosis by Suppressing TLR4 Signaling . Biomed. Pharmacother. 125 , 109868 . 10.1016/j.biopha.2020.109868 32036210 

    상세보기

78. Xie C. Chen Y. Luo D. Zhuang Z. Jin H. Zhou H. ( 2021 ). Therapeutic Potential of C1632 by Inhibition of SARS-CoV-2 Replication and Viral-Induced Inflammation through Upregulating Let-7 . Sig Transduct. Target. Ther. 6 ( 1 ), 84 . 10.1038/s41392-021-00497-4 

    상세보기

79. Xu X. Zhang Y. Li X. Li X. X. ( 2020 ). Analysis on Prevention Plan of corona Virus Disease-19 (COVID-19) by Traditional Chinese Medicine in Various Regions . Chin. Herb. Med. 4 , 866 – 872 . 

80. Xue H. Gan F. Zhang Z. Hu J. Chen X. Huang K. ( 2015 ). Astragalus Polysaccharides Inhibits PCV2 Replication by Inhibiting Oxidative Stress and Blocking NF-κB Pathway . Int. J. Biol. Macromol. 81 , 22 – 30 . 10.1016/j.ijbiomac.2015.07.050 26226456 

    상세보기

81. Yang Y. Islam M. S. Wang J. Li Y. Chen X. ( 2020 ). Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective . Int. J. Biol. Sci. 16 ( 10 ), 1708 – 1717 . 10.7150/ijbs.45538 32226288 

    상세보기

82. Yeh Y. C. Chen H. Y. Yang S. H. Lin Y. H. Chiu J. H. Lin Y. H. ( 2014 ). Hedyotis Diffusa Combined with Scutellaria Barbata Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population-Based Study . Evid. Based Complement. Alternat. Med. 2014 , 202378 . 10.1155/2014/202378 24734104 

    상세보기

83. Yu Y. Zhu C. Wang S. Song W. Yang Y. Shi J. ( 2013 ). Homosecoiridoid Alkaloids with Amino Acid Units from the Flower Buds of Lonicera japonica . J. Nat. Prod. 76 ( 12 ), 2226 – 2233 . 10.1021/np4005773 24279769 

    상세보기

84. Yu J. W. Wang L. Bao L. D. ( 2020 ). Exploring the Active Compounds of Traditional Mongolian Medicine in Intervention of Novel Coronavirus (COVID-19) Based on Molecular Docking Method . J. Funct. Foods 71 , 104016 . 10.1016/j.jff.2020.104016 32421102 

    상세보기

85. Zeng Z. P. Jiang J. G. ( 2010 ). Analysis of the Adverse Reactions Induced by Natural Product-Derived Drugs . Br. J. Pharmacol. 159 ( 7 ), 1374 – 1391 . 10.1111/j.1476-5381.2010.00645.x 20233209 

    상세보기

86. Zhang L. Guo H. ( 2020 ). Biomarkers of COVID-19 and Technologies to Combat SARS-CoV-2 . Adv. Biomark Sci. Technol. 2 , 1 – 23 . 10.1016/j.abst.2020.08.001 33511330 

    상세보기

87. Zhang FX F. X. Li Z. T. Yang X. Xie Z. N. Chen M. H. Yao Z. H. ( 2021 ). Discovery of Anti-flu Substances and Mechanism of Shuang-Huang-Lian Water Extract Based on Serum Pharmaco-Chemistry and Network Pharmacology . J. Ethnopharmacol. 268 , 113660 . 10.1016/j.jep.2020.113660 33276058 

    상세보기

88. Zhang S S. Hong Y. Liu H. Wang Q. Xu J. Zhang Y. ( 2021 ). miR-584 and miR-146 Are Candidate Biomarkers for Acute Respiratory Distress Syndrome . Exp. Ther. Med. 21 ( 5 ), 445 . 10.3892/etm.2021.9873 33747181 

    상세보기

89. Zheng Y. Ren W. Zhang L. Zhang Y. Liu D. Liu Y. ( 2020 ). A Review of the Pharmacological Action of Astragalus Polysaccharide . Front. Pharmacol. 11 , 349 . 10.3389/fphar.2020.00349 32265719 

    상세보기

90. Zhou L. K. Zhou Z. Jiang X. M. Zheng Y. Chen X. Fu Z. ( 2020 ). Absorbed Plant MIR2911 in Honeysuckle Decoction Inhibits SARS-CoV-2 Replication and Accelerates the Negative Conversion of Infected Patients . Cell Discov. 6 , 54 . 10.1038/s41421-020-00197-3 32802404 

    상세보기